{"count": 12, "results": [{"_id": "36595813", "pmid": 36595813, "pmcid": "PMC9794309", "title": "Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report", "journal": "Medicine (Baltimore)", "authors": ["Sun DJ", "He XJ", "Li HT", "Luo BX", "Zhou LX", "Zeng XP", "Li DZ", "Wang W"], "date": "2022-12-23T00:00:00Z", "doi": "10.1097/MD.0000000000032408", "meta_date_publication": "2022 Dec 23", "meta_volume": "101", "meta_issue": "51", "meta_pages": "e32408", "score": 50259.816, "text_hl": "In recent years, many studies believe that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can inhibit the growth of @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumors@@@. ", "citations": {"NLM": "Sun DJ, He XJ, Li HT, Luo BX, Zhou LX, Zeng XP, Li DZ, Wang W. Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report Medicine (Baltimore). 2022 Dec 23;101(51):e32408. PMID: 36595813", "BibTeX": "@article{36595813, title={Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report}, author={Sun DJ and He XJ and Li HT and Luo BX and Zhou LX and Zeng XP and Li DZ and Wang W}, journal={Medicine (Baltimore)}, volume={101}, number={51}, pages={e32408}}"}}, {"_id": "37987968", "pmid": 37987968, "title": "Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?", "journal": "J Gastrointest Cancer", "authors": ["Canha MI", "Ramos G", "Prata R", "Lages Martins P", "Viúla Ramos M", "Coimbra J"], "date": "2023-11-21T00:00:00Z", "doi": "10.1007/s12029-023-00989-2", "meta_date_publication": "2023 Nov 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.96, "text_hl": "The number of @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@ detected was significantly lower in patients under @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (p = 0.014). ", "citations": {"NLM": "Canha MI, Ramos G, Prata R, Lages Martins P, Viúla Ramos M, Coimbra J. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus? J Gastrointest Cancer. 2023 Nov 21;():. PMID: 37987968", "BibTeX": "@article{37987968, title={Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?}, author={Canha MI and Ramos G and Prata R and Lages Martins P and Viúla Ramos M and Coimbra J}, journal={J Gastrointest Cancer}}"}}, {"_id": "33621192", "pmid": 33621192, "title": "Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study.", "journal": "Eur J Endocrinol", "authors": ["Albertelli M", "Nazzari E", "Dotto A", "Grasso LF", "Sciallero S", "Pirchio R", "Rebora A", "Boschetti M", "Pivonello R", "Ricci Bitti S", "Colao AAL", "Ferone D"], "date": "2021-03-01T00:00:00Z", "doi": "10.1530/EJE-20-0795", "meta_date_publication": "2021 Mar", "meta_volume": "184", "meta_issue": "3", "meta_pages": "419-425", "score": 50256.098, "text_hl": "Of the @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@ (including three @DISEASE_Adenocarcinoma @DISEASE_MESH:D000230 @@@adenocarcinomas@@@) only 24% were treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ vs 57% of @SPECIES_9606 @@@patients@@@ without @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@. ", "citations": {"NLM": "Albertelli M, Nazzari E, Dotto A, Grasso LF, Sciallero S, Pirchio R, Rebora A, Boschetti M, Pivonello R, Ricci Bitti S, Colao AAL, Ferone D. Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study. Eur J Endocrinol. 2021 Mar;184(3):419-425. PMID: 33621192", "BibTeX": "@article{33621192, title={Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study.}, author={Albertelli M and Nazzari E and Dotto A and Grasso LF and Sciallero S and Pirchio R and Rebora A and Boschetti M and Pivonello R and Ricci Bitti S and Colao AAL and Ferone D}, journal={Eur J Endocrinol}, volume={184}, number={3}, pages={419-425}}"}}, {"_id": "40353629", "pmid": 40353629, "title": "Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study.", "journal": "Neoplasma", "authors": ["Wang W", "Luo B", "Wang Z", "Zhang J", "Ye Z", "He X", "Li D", "Sun D"], "date": "2025-04-01T00:00:00Z", "doi": "10.4149/neo_2025_250319N130", "meta_date_publication": "2025 Apr", "meta_volume": "72", "meta_issue": "1-2", "meta_pages": "", "score": 50252.36, "text_hl": "@SPECIES_9606 @@@Patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ aged between 40 and 70 years old, with no @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyp@@@ or @DISEASE_Adenoma @DISEASE_MESH:D000236 @@@adenoma@@@ after polypectomy, were randomly assigned to the control (no intervention), low-dose (500 mg/day), or high-dose (1,000 mg/day) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ groups in a 1:1:1 ratio. ", "citations": {"NLM": "Wang W, Luo B, Wang Z, Zhang J, Ye Z, He X, Li D, Sun D. Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study. Neoplasma. 2025 Apr;72(1-2):. PMID: 40353629", "BibTeX": "@article{40353629, title={Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study.}, author={Wang W and Luo B and Wang Z and Zhang J and Ye Z and He X and Li D and Sun D}, journal={Neoplasma}, volume={72}, number={1-2}}"}}, {"_id": "31818851", "pmid": 31818851, "title": "A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.", "journal": "Cancer Prev Res (Phila)", "authors": ["Zell JA", "McLaren CE", "Morgan TR", "Lawson MJ", "Rezk S", "Albers CG", "Chen WP", "Carmichael JC", "Chung J", "Richmond E", "Rodriguez LM", "Szabo E", "Ford LG", "Pollak MN", "Meyskens FL"], "date": "2020-02-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-18-0262", "meta_date_publication": "2020 Feb", "meta_volume": "13", "meta_issue": "2", "meta_pages": "203-212", "score": 50249.137, "text_hl": "The signaling pathway activated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_STK11 @GENE_20869 @@@LKB1@@@/AMPK/@GENE_MTOR @GENE_56717 @@@mTOR@@@) is implicated in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ suppression in ApcMin/+ @SPECIES_10090 @@@mice@@@ via @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced reduction in @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyp@@@ burden, increased ratio of pAMPK/AMPK, decreased pmTOR/@GENE_MTOR @GENE_56717 @@@mTOR@@@ ratio, and decreased pS6Ser235/S6Ser235 ratio in @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@. ", "citations": {"NLM": "Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL. A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prev Res (Phila). 2020 Feb;13(2):203-212. PMID: 31818851", "BibTeX": "@article{31818851, title={A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.}, author={Zell JA and McLaren CE and Morgan TR and Lawson MJ and Rezk S and Albers CG and Chen WP and Carmichael JC and Chung J and Richmond E and Rodriguez LM and Szabo E and Ford LG and Pollak MN and Meyskens FL}, journal={Cancer Prev Res (Phila)}, volume={13}, number={2}, pages={203-212}}"}}, {"_id": "34749618", "pmid": 34749618, "title": "The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.", "journal": "Curr Diabetes Rev", "authors": ["Ala M"], "date": "2022-01-01T00:00:00Z", "doi": "10.2174/1573399818666211105125129", "meta_date_publication": "2022", "meta_volume": "18", "meta_issue": "8", "meta_pages": "e051121197762", "score": 50243.695, "text_hl": "Furthermore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreases the risk of new @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@ and @DISEASE_Adenoma @DISEASE_MESH:D000236 @@@adenomas@@@ in @SPECIES_9606 @@@patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Ala M. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer. Curr Diabetes Rev. 2022;18(8):e051121197762. PMID: 34749618", "BibTeX": "@article{34749618, title={The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.}, author={Ala M}, journal={Curr Diabetes Rev}, volume={18}, number={8}, pages={e051121197762}}"}}, {"_id": "18803638", "pmid": 18803638, "title": "Metformin suppresses intestinal polyp growth in ApcMin/+ mice.", "journal": "Cancer Sci", "authors": ["Tomimoto A", "Endo H", "Sugiyama M", "Fujisawa T", "Hosono K", "Takahashi H", "Nakajima N", "Nagashima Y", "Wada K", "Nakagama H", "Nakajima A"], "date": "2008-11-01T00:00:00Z", "doi": "10.1111/j.1349-7006.2008.00933.x", "meta_date_publication": "2008 Nov", "meta_volume": "99", "meta_issue": "11", "meta_pages": "2136-41", "score": 50060.117, "text_hl": "These factors were not significantly attenuated by the treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, indicating that the suppression of @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyp@@@ growth is not due to the indirect drug action. ", "citations": {"NLM": "Tomimoto A, Endo H, Sugiyama M, Fujisawa T, Hosono K, Takahashi H, Nakajima N, Nagashima Y, Wada K, Nakagama H, Nakajima A. Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Sci. 2008 Nov;99(11):2136-41. PMID: 18803638", "BibTeX": "@article{18803638, title={Metformin suppresses intestinal polyp growth in ApcMin/+ mice.}, author={Tomimoto A and Endo H and Sugiyama M and Fujisawa T and Hosono K and Takahashi H and Nakajima N and Nagashima Y and Wada K and Nakagama H and Nakajima A}, journal={Cancer Sci}, volume={99}, number={11}, pages={2136-41}}"}}, {"_id": "26947328", "pmid": 26947328, "title": "Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.", "journal": "Lancet Oncol", "authors": ["Higurashi T", "Hosono K", "Takahashi H", "Komiya Y", "Umezawa S", "Sakai E", "Uchiyama T", "Taniguchi L", "Hata Y", "Uchiyama S", "Hattori A", "Nagase H", "Kessoku T", "Arimoto J", "Matsuhashi N", "Inayama Y", "Yamanaka S", "Taguri M", "Nakajima A"], "date": "2016-04-01T00:00:00Z", "doi": "10.1016/S1470-2045(15)00565-3", "meta_date_publication": "2016 Apr", "meta_volume": "17", "meta_issue": "4", "meta_pages": "475-483", "score": 50055.7, "text_hl": "The median number of @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@ was zero (IQR 0-1) in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group and one (0-1) in the placebo group (p=0 041). ", "citations": {"NLM": "Higurashi T, Hosono K, Takahashi H, Komiya Y, Umezawa S, Sakai E, Uchiyama T, Taniguchi L, Hata Y, Uchiyama S, Hattori A, Nagase H, Kessoku T, Arimoto J, Matsuhashi N, Inayama Y, Yamanaka S, Taguri M, Nakajima A. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. 2016 Apr;17(4):475-483. PMID: 26947328", "BibTeX": "@article{26947328, title={Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.}, author={Higurashi T and Hosono K and Takahashi H and Komiya Y and Umezawa S and Sakai E and Uchiyama T and Taniguchi L and Hata Y and Uchiyama S and Hattori A and Nagase H and Kessoku T and Arimoto J and Matsuhashi N and Inayama Y and Yamanaka S and Taguri M and Nakajima A}, journal={Lancet Oncol}, volume={17}, number={4}, pages={475-483}}"}}, {"_id": "25349581", "pmid": 25349581, "pmcid": "PMC4204699", "title": "Does Metformin Affect The Incidence of Colonic Polyps and Adenomas in Patients with Type 2 Diabetes Mellitus?", "journal": "Intest Res", "authors": ["Cho YH", "Ko BM", "Kim SH", "Myung YS", "Choi JH", "Han JP", "Hong SJ", "Jeon SR", "Kim HG", "Kim JO", "Lee MS"], "date": "2014-04-01T00:00:00Z", "doi": "10.5217/ir.2014.12.2.139", "meta_date_publication": "2014 Apr", "meta_volume": "12", "meta_issue": "2", "meta_pages": "139-45", "score": 50049.99, "text_hl": "Comparison of the Detection Rate of @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@Polyps and Adenomas@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Group According to the Duration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use", "citations": {"NLM": "Cho YH, Ko BM, Kim SH, Myung YS, Choi JH, Han JP, Hong SJ, Jeon SR, Kim HG, Kim JO, Lee MS. Does Metformin Affect The Incidence of Colonic Polyps and Adenomas in Patients with Type 2 Diabetes Mellitus? Intest Res. 2014 Apr;12(2):139-45. PMID: 25349581", "BibTeX": "@article{25349581, title={Does Metformin Affect The Incidence of Colonic Polyps and Adenomas in Patients with Type 2 Diabetes Mellitus?}, author={Cho YH and Ko BM and Kim SH and Myung YS and Choi JH and Han JP and Hong SJ and Jeon SR and Kim HG and Kim JO and Lee MS}, journal={Intest Res}, volume={12}, number={2}, pages={139-45}}"}}, {"_id": "27318643", "pmid": 27318643, "title": "Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis.", "journal": "Eur J Intern Med", "authors": ["Rokkas T", "Portincasa P"], "date": "2016-09-01T00:00:00Z", "doi": "10.1016/j.ejim.2016.05.027", "meta_date_publication": "2016 Sep", "meta_volume": "33", "meta_issue": "", "meta_pages": "60-6", "score": 50047.375, "text_hl": "OBJECTIVE: We performed a meta-analysis of available studies to better define the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@colon neoplasia@@@ (@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ and @<m>DISEASE_Polyps</m> @DISEASE_MESH:D011127 @@@polyps@@@) in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Rokkas T, Portincasa P. Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis. Eur J Intern Med. 2016 Sep;33():60-6. PMID: 27318643", "BibTeX": "@article{27318643, title={Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis.}, author={Rokkas T and Portincasa P}, journal={Eur J Intern Med}, volume={33}, pages={60-6}}"}}]}